UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043091
Receipt number R000047780
Scientific Title Multicenter prospective observational trial for diagnosing sinusoidal obstruction syndrom/veno occlusive disease by Hokkaido ultrasonography based scoring system
Date of disclosure of the study information 2021/01/26
Last modified on 2022/05/09 16:47:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter trial for diagnosing sinusoidal obstruction syndrom/veno occlusive disease by ultrasonography

Acronym

HokUS-10 trial

Scientific Title

Multicenter prospective observational trial for diagnosing sinusoidal obstruction syndrom/veno occlusive disease by Hokkaido ultrasonography based scoring system

Scientific Title:Acronym

HokUS-10 trial

Region

Japan


Condition

Condition

Sinusoidal obstruction syndrom/ veno occlusive disease

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine Hematology and clinical oncology
Radiology Laboratory medicine Blood transfusion

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluating efficacy of Hokkaido US based scoring system (HokUS-10/6) for early diagnosing SOS/VOD by multicenter prospective observational trial.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Diagnostic performance of HokUS-10/6 for diagnosing SOS/VOD compare to clinical diagnosis as a gold standard

Key secondary outcomes

1 Clinical course of SOS/VOD and transition of HokUS-10/6
2 Onset prediction by base line HokUS-10/6 score before HSCT
3 Comparing the diagnosis date of HokUS-10/6 with clinical diagnosis
4 Evaluation of SOS/VOD severity by HokUS10/6


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Able to have ultrasonography
Informed consent is obtained after enough explanation by adult patient or substitute if minors.

Key exclusion criteria

Autotransplant patients
Not having ultrasonography safely
Not suitable having ultrasonography

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Mutsumi
Middle name
Last name Nishida

Organization

Hokkaido University Hospital

Division name

Department of planning and management

Zip code

0608648

Address

N.15, W. 4, Kita-ku, Sapporo

TEL

+81-011-706-5697

Email

mutuni@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Goto

Organization

Hokkaido University Hospital

Division name

Division of Laboratory and Transfusion Medicine

Zip code

0608648

Address

N.15, W. 4, Kita-ku, Sapporo

TEL

+81-011-706-7784

Homepage URL


Email

hidekigt@med.hokudai.ac.jp


Sponsor or person

Institute

Diagnostic Center for Sonography, Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Nippon Shinyaku Co. Ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Tohoku University Hospital
Fukushima Medical University Hospital
National Cancer Center Hospital
Kobe University Hospital
Okayama University Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, Hokkaido University Hospital

Address

N.14, W.5, Kita-ku, Sapporo

Tel

+81-011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学病院
福島県立医科大学附属病院
国立がん研究センター中央病院
神戸大学医学部附属病院
岡山大学病院 


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

400

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 01 Month 21 Day

Date of IRB

2021 Year 01 Month 21 Day

Anticipated trial start date

2021 Year 02 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patients having HSCT in institutions attending this trial


Management information

Registered date

2021 Year 01 Month 22 Day

Last modified on

2022 Year 05 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047780


Research Plan
Registered date File name
2021/01/26 【承認版】小児同意文書2(小児).pdf

Research case data specifications
Registered date File name

Research case data
Registered date File name